Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -43,447 | -104,468 | -89,871 | -55,996 | -30,522 |
| Depreciation Amortization | 6,978 | 19,687 | 13,601 | 8,707 | 4,183 |
| Accounts receivable | -4,317 | -17,518 | -16,719 | -29,628 | -6,290 |
| Other Working Capital | 10,506 | 140,026 | 187,385 | 6,697 | 7,383 |
| Other Operating Activity | 19,700 | 61,495 | 45,677 | 48,792 | 15,668 |
| Operating Cash Flow | $-10,580 | $99,222 | $140,073 | $-21,428 | $-9,578 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 42,481 | -331,401 | -13,182 | -85,457 | -113,658 |
| PPE Investments | -22,166 | -99,689 | -67,427 | -45,324 | -22,743 |
| Other Investing Activity | 32 | -5,941 | -1,800 | -1,800 | 0 |
| Investing Cash Flow | $20,347 | $-437,031 | $-82,409 | $-132,581 | $-136,401 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 47,544 | 61,304 | 47,544 | 47,544 |
| Debt Repayment | -306 | -1,028 | -757 | -674 | -555 |
| Common Stock Issued | 14,406 | 200,588 | N/A | 12,064 | 9,226 |
| Common Stock Repurchased | -1,063 | -3,798 | N/A | N/A | N/A |
| Financing Cash Flow | $13,037 | $243,306 | $60,547 | $58,934 | $56,215 |
| Beginning Cash Position | 112,572 | 207,075 | 207,075 | 207,075 | 207,075 |
| End Cash Position | 135,376 | 112,572 | 325,286 | 112,000 | 117,311 |
| Net Cash Flow | $22,804 | $-94,503 | $118,211 | $-95,075 | $-89,764 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,580 | 99,222 | 140,073 | -21,428 | -9,578 |
| Capital Expenditure | -22,166 | -99,689 | -67,427 | -45,324 | -22,743 |
| Free Cash Flow | -32,746 | -467 | 72,646 | -66,752 | -32,321 |